Results 71 to 80 of about 2,002 (144)
Abstract The postmortem diagnosis of anaphylaxis remains a forensic challenge due to the lack of specific external signs. Tryptase, a mast cell‐derived protease, has emerged as a potential biomarker for fatal anaphylaxis. This systematic review critically examined 40 studies published between 2014 and 2024, including both biochemical and ...
Luca Tomassini +8 more
wiley +1 more source
Clonal mast cell activation syndromes and indolent systemic mastocytosis without skin involvement are two emerging entities that sometimes might be clinically difficult to distinguish, and they involve a great challenge for the physician from both a ...
David González-de-Olano +3 more
doaj +1 more source
Background Mastocytosis are rare diseases characterized by an accumulation of clonal mast cells (MCs) in one or multiple organs or tissues. Patients with systemic mastocytosis (SM), whose MCs frequently arbor the activating D816V KIT mutation, may have ...
Iolanda Conde-Fernandes +9 more
doaj +1 more source
Allergy, Volume 80, Issue 12, Page 3427-3429, December 2025.
Alessandro Buonomo +6 more
wiley +1 more source
Plenary Abstracts Session & Oral Presentations
HemaSphere, Volume 10, Issue S1, June 2026.
wiley +1 more source
Avapritinib reduces symptoms and mast cell burden in systemic mastocytosis
Background Mastocytosis is driven by a clonal expansion of mast cells, commonly triggered by the KIT D816V mutation which is present in over 90% of adult patients.
Paula Nöldeke +4 more
doaj +1 more source
Indolent systemic mastocytosis in a patient with ileocolitis.
Systemic mastocytosis is a clonal disorder of the mast cell and its progenitor cell. It is a rare disorder with unknown incidence in Greece, with an estimate of 2 cases per year in Great Britain. We present a case of an asymptomatic, 72-year-old man who was found to have ileocolitis on endoscopy.
Georgios, Chrysakopoulos +5 more
openaire +1 more source

